MedTrace Logo

IDEA Study Cognitive Stimulation Therapy (CST) Trial in Nigeria

NCT02233530 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2021-06-21

Study results available
· View outcomes & findings →

Summary

This trials of cognitive stimulation therapy (CST) in Tanzania is part of the larger Identification and Intervention for Dementia in Elderly Africans (IDEA) study.

The overall aim of the IDEA study is to set up and evaluate sustainable programmes to facilitate diagnosis of, and therapy for, people with dementia led by local communities in sub-Saharan Africa. The investigators seek to improve quality of life for people with dementia and their caregivers.

Within this trial of CST, the investigators hypothesise that CST can significantly improve the quality of people with dementia and their carers living in Africa

Conditions

Interventions

BEHAVIORAL

CST intervention

The CST intervention comprises 14 sessions lasting 1-2 hours across 7 weeks. The CST manual has been adapted for use in this setting by members of our study team. Each session has a theme. Activities include tasks aimed at engaging participants in cognitive and physical tasks designed to improve quality of life. Sessions will be led and facilitated by a study nurse or occupational therapist. The sessions will be held at a local health centre of village hall.

Sponsors & Collaborators

  • Grand Challenges Canada

    collaborator OTHER

  • University of Ibadan

    collaborator OTHER

  • Kilimanjaro Christian Medical Centre, Tanzania

    collaborator OTHER

  • Newcastle University

    collaborator OTHER

  • Northumbria Healthcare NHS Foundation Trust

    collaborator OTHER

  • William Keith Gray

    lead OTHER

Principal Investigators

  • Adesola Ogunniyi, MD · University of Ibadan, Nigeria

  • Akin Adebiyi · University of Ibadan

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-03-31
Completion
2015-09-30

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02233530 on ClinicalTrials.gov